Recovery of parathyroid function in patients with thyroid cancer treated by total thyroidectomy: An analysis of 685 patients with hypoparathyroidism at discharge of surgery
Juan J. Díez(Instituto Cajal), Pedro Iglesias(Hospital Universitario Puerta de Hierro Majadahonda), Concepción Blanco-Carrera(Hospital Universitario Príncipe de Asturias), Cecilia Sánchez-Ragnarsson(Hospital Universitario Central de Asturias), Sergio Donnay(Hospital Universitario Fundación Alcorcón), Juan C. Galofré(Instituto de Salud Pública de Navarra), Ana Megía(Institut de Recerca Biomèdica Catalunya Sud), José Carlos Fernández‐García(Hospital Universitario Puerta de Hierro Majadahonda), Carles Zafón(Vall d'Hebron Hospital Universitari), Laura Manjón(Hospital Universitario Central de Asturias), Emma Anda(Complejo Hospitalario de Navarra), Orosia Bandrés(Hospital Royo Villanova), Cristina Álvarez‐Escolá(Hospital Universitario La Paz), Gloria Baena‐Nieto(Hospital Jerez Puerta del Sur), Ana R. Romero-Lluch(Hospital Universitario Virgen del Rocío), Piedad Santiago-Fernández(Complejo Hospitalario de Jaén), María Picallo(Hospital General Universitario Gregorio Marañón), Manel Sahún de la Vega(Hospital de Sant Joan Despí Moisès Broggi), Laura Oleaga(Hospital de Basurto), Marcel Sambo(Hospital General Universitario Gregorio Marañón), Begoña Pérez-Corral(Complejo Asistencial Universitario de Palencia), Eva Sanz(Vall d'Hebron Hospital Universitari), Miguel Paja(Hospital de Basurto), Beatriz Lecumberri(Hospital Universitario La Paz), Julia Sastre(Complejo Hospitalario Universitario de Toledo), Elena Navarro(Hospital Universitario Virgen del Rocío)
Cited by 2
Related Papers
Diagnosis and management of pseudohypoparathyroidism and related disorders: first international Consensus Statement
|Nature Reviews Endocrinology|2018|346
Clinical and genetic characterization of pituitary gigantism: an international collaborative study in 208 patients
|Endocrine Related Cancer|2015|204
From pseudohypoparathyroidism to inactivating PTH/PTHrP signalling disorder (iPPSD), a novel classification proposed by the EuroPHP network
|European Journal of Endocrinology|2016|174
Pazopanib in pretreated advanced neuroendocrine tumors: a phase II, open-label trial of the Spanish Task Force Group for Neuroendocrine Tumors (GETNE)
|Annals of Oncology|2015|157
GLUT1 deficiency and other glucose transporter diseases
|European Journal of Endocrinology|2004|145